Temozolomide versus 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial

被引：0
|
作者：
机构：
来源：
International Journal of Radiation Oncology Biology Physics | 2013年 / 85卷 / 02期
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：284 / 285
相关论文
共 50 条
  • [1] Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
    Malmstrom, Annika
    Gronberg, Bjorn Henning
    Marosi, Christine
    Stupp, Roger
    Frappaz, Didier
    Schultz, Henrik
    Abacioglu, Ufuk
    Tavelin, Bjorn
    Lhermitte, Benoit
    Hegi, Monika E.
    Rosell, Johan
    Henriksson, Roger
    LANCET ONCOLOGY, 2012, 13 (09): : 916 - 926
  • [2] Glioblastoma treatment in patients older than 60 years: Hypofractionated radiotherapy and temozolomide versus conventional radiotherapy and temozolomide
    Pacheco, T.
    Mueller, M.
    Delgado, D. D. C. M. E. S.
    de Abrunhosa Branquinho, A. N.
    Figueiredo, A.
    Marques Da Costa, L. A.
    Albuquerque, M. L.
    ANNALS OF ONCOLOGY, 2023, 34 : S404 - S404
  • [3] HYPOFRACTIONATED VERSUS STANDARD RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE FOR ELDERLY PATIENTS WITH GLIOBLASTOMA
    Gkogkou, P.
    Hamm, S.
    Geropantas, K.
    Ajithkumar, T.
    Jefferies, S.
    NEURO-ONCOLOGY, 2017, 19 : 71 - 71
  • [4] Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)
    Malmstrom, A.
    Gronberg, B. H.
    Stupp, R.
    Marosi, C.
    Frappaz, D.
    Schultz, H. P.
    Abacioglu, M. U.
    Kinhult, S.
    Henriksson, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [5] Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial
    Malmstrom, Annika
    Poulsen, Hans Skovgaard
    Gronberg, Bjorn Henning
    Stragliotto, Giuseppe
    Hansen, Steinbjorn
    Asklund, Thomas
    Holmlund, Birgitta
    Lysiak, Malgorzata
    Dowsett, Joseph
    Kristensen, Bjarne Winther
    Soderkvist, Peter
    Rosell, Johan
    Henriksson, Roger
    ACTA ONCOLOGICA, 2017, 56 (12) : 1776 - 1785
  • [6] BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH GLIOBLASTOMA: THE ARTE TRIAL
    Wirsching, H. G.
    Tabatabai, G.
    Hottinger, A.
    Plasswilm, L.
    Roelcke, U.
    Conen, K.
    Held, L.
    Rushing, E. J.
    Ochsenbein, A.
    Weller, M.
    NEURO-ONCOLOGY, 2017, 19 : 13 - 13
  • [7] Short Course Hypofractionated Radiotherapy versus Conventional Radiotherapy for Poor Prognosis Glioblastoma Multiforme: A Randomised Controlled Trial
    Choudhary, Sunil
    Gupta, Neha
    Lal, Punita
    Kumar, Shaleen
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (03) : XC01 - XC04
  • [8] Hypofractionated (HRT) versus standard (SRT) radiotherapy with or without temozolomide (T) for elderly patients with glioblastoma (GBM).
    Tanguturi, Shyam Kumar
    Wen, Patrick Y.
    Reardon, David A.
    Lee, Eudocia Quant
    Nayak, Lakshmi
    Christianson, Laura W.
    Horvath, Margaret C.
    Dunn, Ian F.
    Golby, Alexandra J.
    Johnson, Mark D.
    Claus, Elizabeth B.
    Chiocca, E. Antonio
    Ligon, Keith L.
    Alexander, Brian Michael
    Arvold, Nils D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Weller, Michael
    Tabatabai, Ghazaleh
    Roelcke, Ulrich
    Hottinger, Andreas
    Joerger, Francisca
    Schmid, Andrea
    Plasswilm, Ludwig
    Schrimpf, Daniel
    Mancao, Christoph
    Capper, David
    Conen, Katrin
    Hundsberger, Thomas
    Caparrotti, Francesca
    von Moos, Roger
    Riklin, Christian
    Felsberg, Joerg
    Roth, Patrick
    Jones, David
    Pfister, Stefan M.
    Rushing, Elisabeth Jane
    Abrey, Lauren
    Reifenberger, Guido
    Held, Leonhard
    von Deimling, Andreas
    Ochsenbein, Adrian
    Wirsching, Hans-Georg
    NEURO-ONCOLOGY, 2017, 19 : 2 - 2
  • [10] PHASE II RANDOMIZED TRIAL OF SHORT COURSE HYPOFRACTIONATED RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA
    Madan, R.
    Thakur, S.
    Salunke, P.
    Ahuja, C.
    Khosla, D.
    Yadav, B. S.
    Kapoor, R.
    Kumar, N.
    NEURO-ONCOLOGY, 2019, 21 : 67 - 67
12345